Organic Label Claims 101: What Hemp Businesses Need To Know Before Claiming “Organic” the Product Label

If you operate a business that manufactures, distributes, and/or sells hemp foods, supplements, or cosmetic products, your product may contain some organic ingredients. Your products may also include hemp extract ingredients derived from USDA-certified “organic” hemp crops. But what does this mean in terms of reflecting these organic ingredients on your product’s label? If your

By |2020-09-21T12:33:38-06:00September 21st, 2020|Government and Policy|

Can Congress Speed Up CBD Regulation?

Experts weigh in on the various legislative pathways WASHINGTON — Having already submitted two congressionally mandated reports on cannabidiol (CBD), it’s looking less and less likely that the U.S. Food and Drug Administration (FDA) will release the long-awaited regulations that would provide a pathway for ingestible products. Leaving many in the industry to question if Congress

By |2020-09-14T08:43:17-06:00September 14th, 2020|HLG In The News|

4 Takeaways From the FDA’s CBD Accuracy Report

Multiyear studies show the industry is improving but could be better WASHINGTON — The U.S. Food and Drug Administration (FDA) submitted a report to Congress in July outlining numerous studies the agency has conducted to determine the labeling accuracy of various cannabidiol (CBD) products. As covered by Marijuana Moment, the report was the second mandated

By |2020-09-09T10:33:27-06:00August 10th, 2020|HLG In The News|

Cannabinoids Molecules in Motion

Written By Dennis Brovarone Most people interested in cannabis have learned there are over one hundred different molecules known as “cannabinoids” found in cannabis flowers with THC ( tetrahydrocannabinol) and CBD (cannabidiol ) being the best known while CBN (cannabinol) rapidly attracting scientific research and consumer demand.  People are also aware that cannabinoids interact with the

By |2020-08-04T13:31:01-06:00August 4th, 2020|Uncategorized|

Hemp CBD vs Marijuana CBD: What’s the Difference?

Differences Between Marijuana CBD and Hemp CBD Cannabidiol (or “CBD” for short) has gained immense popularity on the market in the U.S. and beyond over the last several years. CBD is just one of the many naturally-occurring phytocannabinoids found in the cannabis plant. Unlike THC (tetrahydrocannabinol), which is typically associated with causing a “high” in

By |2020-09-04T10:34:41-06:00August 4th, 2020|Hemp|

The CBD “Industry” Is Here To Stay

Written By: Robert Hoban Hemp legalization has solidified that products containing cannabidiol (CBD) aren’t going away. Last February, Stephen Hahn, Commissioner of the Food and Drug Administration (FDA), acknowledged that it was “a fool's game” to attempt to pull hemp-derived CBD products off the market. This echoes the sentiment of former interim Commissioner, Scott Gottlieb, who’d

By |2020-08-03T08:43:11-06:00August 3rd, 2020|HLG In The News|

What is a Cannabinoid?

Written By: Eric Singular Cannabis contains an array of unique chemicals, known as cannabinoids. The most prolific of these is tetrahydrocannabinol (THC), the psychoactive compound that legally distinguishes marijuana from industrial hemp. The other prominent cannabinoid, the one you’ve likely kept hearing about since the passage of the 2014 Farm Bill, is cannabidiol, better known

By |2020-08-04T13:01:37-06:00July 28th, 2020|Hemp|

Federal COVID-19 Response Leaves Some Cannabis Businesses in the Cold

Written by Darren Kaplan & Jana Weltzin As businesses around the United States reckon with the unfolding realities of the COVID-19 pandemic, the cannabis industry has continued to experience the consequences of divergent federal and state policies. On one hand, the hemp side of the cannabis industry is reaping the rewards of national legalization by

By |2020-04-10T09:08:54-06:00April 9th, 2020|Government and Policy|

The Hoban Minute – 25 Breaking News: DEA Removes Epidiolex From Controlled Substances List

The Hoban Minute - 25 Breaking News: DEA Removes Epidiolex From Controlled Substances List On April 6th, the DEA announced that Epidiolex, the first Cannabis-formulated drug to be approved by the FDA in 2018, was being removed from the Controlled Substances List. Bob and Eric discuss the significance of this development, and whether it will

By |2020-07-08T15:46:43-06:00April 8th, 2020|The Hoban Minute|

FDA Issues Warning Letter to CBD Company for Fraudulent COVID-19 Treatment Claims

On Tuesday, the Food and Drug Administration (“FDA”) and the Federal Trade Commission (“FTC”) issued a Warning Letter issued to Neuro XPF, a company selling CBD products in the U.S., based on claims contained on its website and social media pages that its products can mitigate, prevent, treat, diagnose, or cure COVID-19. The FDA has

By |2020-04-03T15:12:28-06:00April 2nd, 2020|Government and Policy|
Go to Top